These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 15294950)

  • 21. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors.
    Hejazi N; Zhou C; Oz M; Sun H; Ye JH; Zhang L
    Mol Pharmacol; 2006 Mar; 69(3):991-7. PubMed ID: 16332990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila.
    Lu T; Newton C; Perkins I; Friedman H; Klein TW
    Eur J Pharmacol; 2006 Feb; 532(1-2):170-7. PubMed ID: 16443217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
    Athanasiou A; Clarke AB; Turner AE; Kumaran NM; Vakilpour S; Smith PA; Bagiokou D; Bradshaw TD; Westwell AD; Fang L; Lobo DN; Constantinescu CS; Calabrese V; Loesch A; Alexander SP; Clothier RH; Kendall DA; Bates TE
    Biochem Biophys Res Commun; 2007 Dec; 364(1):131-7. PubMed ID: 17931597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.
    Braun A; Engel T; Aguilar-Pimentel JA; Zimmer A; Jakob T; Behrendt H; Mempel M
    Immunobiology; 2011 Apr; 216(4):466-76. PubMed ID: 21056512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
    Pertwee RG
    Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
    Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
    Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential role of cannabinoids in the pathogenesis of skin cancer.
    Glodde N; Jakobs M; Bald T; Tüting T; Gaffal E
    Life Sci; 2015 Oct; 138():35-40. PubMed ID: 25921771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
    McKallip RJ; Lombard C; Fisher M; Martin BR; Ryu S; Grant S; Nagarkatti PS; Nagarkatti M
    Blood; 2002 Jul; 100(2):627-34. PubMed ID: 12091357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.
    Jiang S; Fu Y; Williams J; Wood J; Pandarinathan L; Avraham S; Makriyannis A; Avraham S; Avraham HK
    PLoS One; 2007 Jul; 2(7):e641. PubMed ID: 17653268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
    Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
    Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
    Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.
    Michler T; Storr M; Kramer J; Ochs S; Malo A; Reu S; Göke B; Schäfer C
    Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G181-92. PubMed ID: 23139224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B).
    Jüttler E; Potrovita I; Tarabin V; Prinz S; Dong-Si T; Fink G; Schwaninger M
    Neuropharmacology; 2004 Sep; 47(4):580-92. PubMed ID: 15380375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
    Welch SP; Huffman JW; Lowe J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anandamide effects on 5-HT(3) receptors in vivo.
    Rácz I; Bilkei-Gorzo A; Markert A; Stamer F; Göthert M; Zimmer A
    Eur J Pharmacol; 2008 Oct; 596(1-3):98-101. PubMed ID: 18775693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
    Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
    Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE; Kendall DA; Randall MD
    Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Introduction to the Endogenous Cannabinoid System.
    Lu HC; Mackie K
    Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.